Author details

Full Name

Oliver J Semmes

Affiliation

Eastern Virginia Medical School

ORCID

Career Start Year

1985

Papers

157

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36097168	Prospective comparison of restriction spectrum imaging and non-invasive biomarkers to predict upgrading on active surveillance prostate biopsy.	Prostate Cancer Prostatic Dis	2024
36922981	promor: a comprehensive R package for label-free proteomics data analysis and predictive modeling.	Bioinform Adv	2023
37546794	Prostate Cancer Reshapes the Secreted and Extracellular Vesicle Urinary Proteomes.	bioRxiv	2023
35119778	Optimization of small extracellular vesicle isolation from expressed prostatic secretions in urine for in-depth proteomic analysis.	J Extracell Vesicles	2022
36061737	Site-Specific Intact N-Linked Glycopeptide Characterization of Prostate-Specific Membrane Antigen from Metastatic Prostate Cancer Cells.	ACS Omega	2022
34680183	Reinspection of a Clinical Proteomics Tumor Analysis Consortium (CPTAC) Dataset with Cloud Computing Reveals Abundant Post-Translational Modifications and Protein Sequence Variants.	Cancers (Basel)	2021
33649200	NF-ÎºB-induced R-loop accumulation and DNA damage select for nucleotide excision repair deficiencies in adult T cell leukemia.	Proc Natl Acad Sci U S A	2021
34646811	Direct N-Glycosylation Profiling of Urine and Prostatic Fluid Glycoproteins and Extracellular Vesicles.	Front Chem	2021
34453155	Proteomic discovery of non-invasive biomarkers of localized prostate cancer using mass spectrometry.	Nat Rev Urol	2021
32453758	RNF8 Dysregulation and Down-regulation During HTLV-1 Infection Promote Genomic Instability in Adult T-Cell Leukemia.	PLoS Pathog	2020
33306747	Correction: The Tudor Domain Protein Spindlin1 Is Involved in Intrinsic Antiviral Defense against Incoming Hepatitis B Virus and Herpes Simplex Virus Type 1.	PLoS Pathog	2020
33093161	Prostate Cancer Biomarker Development: National Cancer Institute's Early Detection Research Network Prostate Cancer Collaborative Group Review.	Cancer Epidemiol Biomarkers Prev	2020
32614141	Targeted Mass Spectrometry of a Clinically Relevant PSA Variant from Post-DRE Urines for Quantitation and Genotype Determination.	Proteomics Clin Appl	2020
31434495	Endothelial-to-Mesenchymal Transition in Human Adipose Tissue Vasculature Alters the Particulate Secretome and Induces Endothelial Dysfunction.	Arterioscler Thromb Vasc Biol	2019
29330297	Characterization and Evidence of the miR-888 Cluster as a Novel Cancer Network in Prostate.	Mol Cancer Res	2018
29283216	A Lipidomics Approach to Identifying Key Lipid Species Involved in VEGF-Inhibitor Mediated Attenuation of Bleomycin-Induced Pulmonary Fibrosis.	Proteomics Clin Appl	2018
28156212	Changes in the Hippocampal Proteome Associated with Spatial Memory Impairment after Exposure to Low (20 cGy) Doses of 1 GeV/n <sup>56</sup>Fe Radiation.	Radiat Res	2017
27322308	HTLV-1 Infection and Adult T-Cell Leukemia/Lymphoma-A Tale of Two Proteins: Tax and HBZ.	Viruses	2016
26530043	Complex-I Alteration and Enhanced Mitochondrial Fusion Are Associated With Prostate Cancer Progression.	J Cell Physiol	2016
26425798	A proteomics approach to identifying key protein targets involved in VEGF inhibitor mediated attenuation of bleomycin-induced pulmonary fibrosis.	Proteomics	2016
27350604	Targeted proteomics identifies liquid-biopsy signatures for extracapsular prostate cancer.	Nat Commun	2016
26285145	HTLV-1 Tax Stimulates Ubiquitin E3 Ligase, Ring Finger Protein 8, to Assemble Lysine 63-Linked Polyubiquitin Chains for TAK1 and IKK Activation.	PLoS Pathog	2015
26497208	Dysregulated expression of cell surface glycoprotein CDCP1 in prostate cancer.	Oncotarget	2015
24200968	miR-888 is an expressed prostatic secretions-derived microRNA that promotes prostate cell growth and migration.	Cell Cycle	2014
25593999	MDA-9/Syntenin regulates differentiation and angiogenesis programs in head and neck squamous cell carcinoma.	Oncoscience	2014
25211330	The Tudor domain protein Spindlin1 is involved in intrinsic antiviral defense against incoming hepatitis B Virus and herpes simplex virus type 1.	PLoS Pathog	2014
24371063	Histone deacetylase inhibitors potentiate vesicular stomatitis virus oncolysis in prostate cancer cells by modulating NF-ÎºB-dependent autophagy.	J Virol	2014
23247814	The search for biomarkers of human embryo developmental potential in IVF: a comprehensive proteomic approach.	Mol Hum Reprod	2013
23966382	Restriction of virus infection but not catalytic dNTPase activity is regulated by phosphorylation of SAMHD1.	J Virol	2013
23775902	Increased bisecting N-acetylglucosamine and decreased branched chain glycans of N-linked glycoproteins in expressed prostatic secretions associated with prostate cancer progression.	Proteomics Clin Appl	2013
23780814	Focus on cancer proteomics.	Proteomics Clin Appl	2013
23388725	Methyltransferase PRMT1 is a binding partner of HBx and a negative regulator of hepatitis B virus transcription.	J Virol	2013
23533145	In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.	Proteomics	2013
22098105	Tissue imaging using nanospray desorption electrospray ionization mass spectrometry.	Anal Chem	2012
22986220	Identification of differentially expressed proteins in direct expressed prostatic secretions of men with organ-confined versus extracapsular prostate cancer.	Mol Cell Proteomics	2012
23107099	NADiA ProsVue prostate-specific antigen slope is an independent prognostic marker for identifying men at reduced risk of clinical recurrence of prostate cancer after radical prostatectomy.	Urology	2012
22782996	Proteomic and pathway analyses reveal a network of inflammatory genes associated with differences in skin tumor promotion susceptibility in DBA/2 and C57BL/6 mice.	Carcinogenesis	2012
22645331	BclAF1 restriction factor is neutralized by proteasomal degradation and microRNA repression during human cytomegalovirus infection.	Proc Natl Acad Sci U S A	2012
22339264	Identification of prostate-enriched proteins by in-depth proteomic analyses of expressed prostatic secretions in urine.	J Proteome Res	2012
22106342	The Sumo-targeted ubiquitin ligase RNF4 regulates the localization and function of the HTLV-1 oncoprotein Tax.	Blood	2012
21190259	Enhancement in MALDI-TOF MS analysis of the low molecular weight human serum proteome.	J Mass Spectrom	2011
21865299	Functional and physical interaction between the mismatch repair and FA-BRCA pathways.	Hum Mol Genet	2011
21853197	Using boronolectin in MALDI-MS imaging for the histological analysis of cancer tissue expressing the sialyl Lewis X antigen.	Chem Commun (Camb)	2011
21541816	MALDI tissue imaging: from biomarker discovery to clinical applications.	Anal Bioanal Chem	2011
21656913	On-tissue identification of insulin: in situ reduction coupled with mass spectrometry imaging.	Proteomics Clin Appl	2011
21711701	A proteomic study of TAR-RNA binding protein (TRBP)-associated factors.	Cell Biosci	2011
21734044	Direct and specific binding of the UL16 tegument protein of herpes simplex virus to the cytoplasmic tail of glycoprotein E.	J Virol	2011
21751409	Improved signal processing and normalization for biomarker protein detection in broad-mass-range TOF mass spectra from clinical samples.	Proteomics Clin Appl	2011
21697344	Human endogenous retrovirus transcription profiles of the kidney and kidney-derived cell lines.	J Gen Virol	2011
21332380	Challenges to developing proteomic-based breast cancer diagnostics.	OMICS	2011

1 - 50 of 157

Qing Zhang

Beijing Hospital of Traditional Chinese Medicine, Capital Medical University

Career Start Year 2006

Number of shared co-authors 0

Brian L Hood

The Henry M. Jackson Foundation for the Advancement of Military Medicine

Career Start Year 2004

Number of shared co-authors 6

Sharon J Pitteri

Stanford University

Career Start Year 2003

Number of shared co-authors 5

Feng Yang

Howard Hughes Medical Institute, University of California San Diego

Career Start Year 2003

Number of shared co-authors 6

Andrew V Kossenkov

The Wistar Institute

Career Start Year 2003

Number of shared co-authors 1

Jayantha Gunaratne

Institute of Molecular and Cell Biology

Career Start Year 2000

Number of shared co-authors 0

Emily S Boja

Office of Cancer Clinical Proteomics Research, National Cancer Institute

Career Start Year 2000

Number of shared co-authors 5

Tamar Geiger

Tel Aviv University

Career Start Year 2000

Number of shared co-authors 0

Parag Mallick

Stanford University

Career Start Year 2000

Number of shared co-authors 4

Alex Kentsis

Memorial Sloan-Kettering Cancer Center

Career Start Year 1998

Number of shared co-authors 0

Dongquan Chen

University of Alabama at Birmingham

Career Start Year 1997

Number of shared co-authors 1

Janne Lehti??

Karolinska Institutet

Career Start Year 1997

Number of shared co-authors 0

Mu Wang

Academy of Pharmacy, Xi'an Jiaotong-Liverpool University

Career Start Year 1996

Number of shared co-authors 0

Donald J Johann

Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences

Career Start Year 1996

Number of shared co-authors 2

Robert Kim

University of California

Career Start Year 1996

Number of shared co-authors 1

Tara Hiltke

Office of Cancer Clinical Proteomics Research, National Cancer Institute

Career Start Year 1994

Number of shared co-authors 6

Michael R Emmert-Buck

The Francis Crick Institute

Career Start Year 1994

Number of shared co-authors 2

Wenbin Wei

Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield

Career Start Year 1991

Number of shared co-authors 0

Kevin R Coombes

Medical College of Georgia

Career Start Year 1990

Number of shared co-authors 3

Ronald C Hendrickson

Memorial Sloan Kettering Cancer Center

Career Start Year 1990

Number of shared co-authors 5

David Feny??

Institute for Systems Genetics, NYU Grossman School of Medicine

Career Start Year 1989

Number of shared co-authors 4

Stephen M Hewitt

Center for Cancer Research, National Cancer Institute

Career Start Year 1988

Number of shared co-authors 4

Stephen R Pennington

UCD Conway Institute, University College Dublin

Career Start Year 1985

Number of shared co-authors 5

Henry Rodriguez

Office of Cancer Clinical Proteomics Research, National Cancer Institute

Career Start Year 1983

Number of shared co-authors 13

Ryuji Kobayashi

Tokyo University of Science

Career Start Year 1979

Number of shared co-authors 1

Samir M Hanash

University of Texas MD Anderson Cancer Center

Career Start Year 1977

Number of shared co-authors 15

Gordon B Mills

Knight Cancer Institute, Oregon Health and Sciences University

Career Start Year 1976

Number of shared co-authors 11

Karin D Rodland

Oregon Health and Science University

Career Start Year 1973

Number of shared co-authors 10

Edouard C Nice

Monash University

Career Start Year 1971

Number of shared co-authors 8

John N Weinstein

The University of Texas MD Anderson Cancer Center

Career Start Year 1968

Number of shared co-authors 2

row(s) 1 - 30 of 30

Richard R Drake

Medical University of South Carolina

Co-authored papers 34

Julius O Nyalwidhe

Eastern Virginia Medical School

Co-authored papers 26

Dean A Troyer

Eastern Virginia Medical School

Co-authored papers 18

Raymond S Lance

Washington State University Elson S. Floyd College of Medicine

Co-authored papers 17

Thomas Kislinger

Princess Margaret Cancer Centre, University Health Network, University of Toronto

Co-authored papers 9

William E Grizzle

University of Alabama at Birmingham

Co-authored papers 7

Paul C Boutros

University of California los angeles

Co-authored papers 7

Zhen Zhang

Co-authored papers 6

Ian M Thompson

CHRISTUS Santa Rosa Hospital-Medical Center

Co-authored papers 6

Daniel W Chan

Division of Clinical Chemistry, Johns Hopkins University

Co-authored papers 6

Sudhir Srivastava

National Cancer Institute

Co-authored papers 5

Yunee Kim

University of Toronto

Co-authored papers 5

Vladimir Ignatchenko

Margaret Cancer Center

Co-authored papers 5

Lifang Yang

Cancer Research Institute, Central South University

Co-authored papers 4

Shiv Srivastava

Co-authored papers 4

Alan W Partin

The Brady Urological Institute, Johns Hopkins University School of Medicine

Co-authored papers 4

Robin J Leach

University of Texas Health San Antonio

Co-authored papers 4

Michael A Liss

University of Texas Health San Antonio

Co-authored papers 3

Joseph J Otto

Leroy T. Canoles Jr. Cancer Research Center, Eastern Virginia Medical School

Co-authored papers 3

Lori J Sokoll

Division of Clinical Chemistry, Johns Hopkins University

Co-authored papers 3

Jeffrey A Medin

Medical College of Wisconsin

Co-authored papers 3

Brian P Main

Leroy T. Canoles Jr. Cancer Research Center, Eastern Virginia Medical School

Co-authored papers 3

Steven Hayward

Johns Hopkins University School of Medicine

Co-authored papers 3

Danny Vesprini

University of Toronto, Canada Odette Cancer Centre

Co-authored papers 2

Stanley K Liu

Odette Cancer Centre, University of Toronto

Co-authored papers 2

Lydia Y Liu

University of Toronto

Co-authored papers 2

Teresa L Johnson-Pais

University of Texas Health San Antonio

Co-authored papers 2

Vitold E Galkin

Eastern Virginia Medical School

Co-authored papers 2

Cindy Q Yao

Ontario Institute for Cancer Research

Co-authored papers 2

Michelle R Downes

University of Toronto

Co-authored papers 2

1 - 30

Author Details

Column Actions

Recommended Authors

Collaborators